K251978

Substantially Equivalent

LIAISON NES FLU A/B, RSV & COVID-19

Applicant: Diasorin Molecular, LLC
Product code: QOF
Advisory panel: Microbiology
Date received: 2025-06-27
Decision date: 2025-12-23
Decision: Substantially Equivalent
Clearance type: Dual Track
Location: Cypress, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.